Page last updated: 2024-08-05 13:25:49
rifamycins
null
ChEBI ID: 26580
Members (5)
Member | Definition | Role |
---|---|---|
rifampin | A member of the class of rifamycins that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei). | rifampicin zwitterion; rifampicin |
rifamycin b | rifamycin B | |
rifamycin sv | A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. | rifamycin SV |
rifapentine | rifapentine | |
rifaximin | A semisynthetic member of the class of rifamycins and non-systemic gastrointestinal site-specific broad spectrum antibiotic. Used in the treatment of traveller's diarrhoea, hepatic encephalopathy and irritable bowel syndrome. | rifaximin |
Research
Studies (19,441)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 6,257 (32.18) | 18.7374 |
1990's | 2,555 (13.14) | 18.2507 |
2000's | 3,523 (18.12) | 29.6817 |
2010's | 5,186 (26.68) | 24.3611 |
2020's | 1,920 (9.88) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 1,587 (7.41%) | 5.53% |
Reviews | 1,319 (6.16%) | 6.00% |
Case Studies | 2,868 (13.40%) | 4.05% |
Observational | 111 (0.52%) | 0.25% |
Other | 15,520 (72.51%) | 84.16% |